Getinge AB ser. B Total Liabilities
Getinge AB ser. B total liabilities. Based on the latest financial reports, Getinge AB ser. B (GETI-B) has total liabilities worth Skr26.37 Billion SEK (≈ $2.84 Billion USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Getinge AB ser. B to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Getinge AB ser. B (2002–2025)
Total liabilities of Getinge AB ser. B from 2002 to 2025. This chart illustrates how Getinge AB ser. B's total liabilities have evolved over time, based on quarterly financial data. Explore long-term investment intensity of Getinge AB ser. B to see how much of total assets are deployed in long-term investments.
Getinge AB ser. B Competitors by Total Liabilities
The table below lists competitors of Getinge AB ser. B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Eastman Chemical Company
NYSE:EMN
|
USA | $9.14 Billion |
|
Pearson plc
F:PESA
|
Germany | €2.79 Billion |
|
Primo Brands Corporation
NYSE:PRMB
|
USA | $7.66 Billion |
|
SM Energy Co
NYSE:SM
|
USA | $12.28 Billion |
|
AURUBIS AG UNSP.ADR 1/2
F:NDA1
|
Germany | €4.49 Billion |
|
Public Power Corporation S.A.
AT:PPC
|
Greece | €22.32 Billion |
|
Eva Airways Corp
TW:2618
|
Taiwan | NT$247.24 Billion |
|
Tencent Music Entertainment Group
F:63TA
|
Germany | €22.72 Billion |
Liability Composition Analysis (2002–2025)
This chart breaks down Getinge AB ser. B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Getinge AB ser. B.
Liquidity & Leverage Metrics
Getinge AB ser. B Total Liabilities Ratios Explained
Getinge AB ser. B total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.31 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.85 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Getinge AB ser. B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Getinge AB ser. B (2002–2025)
The table below shows the annual total liabilities of Getinge AB ser. B from 2002 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr27.01 Billion ≈ $2.91 Billion |
-12.04% |
| 2024-12-31 | Skr30.71 Billion ≈ $3.30 Billion |
+32.46% |
| 2023-12-31 | Skr23.18 Billion ≈ $2.49 Billion |
+7.43% |
| 2022-12-31 | Skr21.58 Billion ≈ $2.32 Billion |
+11.35% |
| 2021-12-31 | Skr19.38 Billion ≈ $2.09 Billion |
-17.63% |
| 2020-12-31 | Skr23.53 Billion ≈ $2.53 Billion |
-0.89% |
| 2019-12-31 | Skr23.74 Billion ≈ $2.55 Billion |
+0.18% |
| 2018-12-31 | Skr23.70 Billion ≈ $2.55 Billion |
+6.28% |
| 2017-12-31 | Skr22.30 Billion ≈ $2.40 Billion |
-34.99% |
| 2016-12-31 | Skr34.30 Billion ≈ $3.69 Billion |
+1.94% |
| 2015-12-31 | Skr33.64 Billion ≈ $3.62 Billion |
-1.41% |
| 2014-12-31 | Skr34.12 Billion ≈ $3.67 Billion |
+23.00% |
| 2013-12-31 | Skr27.74 Billion ≈ $2.99 Billion |
+0.08% |
| 2012-12-31 | Skr27.72 Billion ≈ $2.98 Billion |
+3.31% |
| 2011-12-31 | Skr26.83 Billion ≈ $2.89 Billion |
+25.76% |
| 2010-12-31 | Skr21.34 Billion ≈ $2.30 Billion |
-14.43% |
| 2009-12-31 | Skr24.94 Billion ≈ $2.68 Billion |
+11.54% |
| 2008-12-31 | Skr22.36 Billion ≈ $2.41 Billion |
+36.58% |
| 2007-12-31 | Skr16.37 Billion ≈ $1.76 Billion |
+65.80% |
| 2006-12-31 | Skr9.87 Billion ≈ $1.06 Billion |
+7.87% |
| 2005-12-31 | Skr9.15 Billion ≈ $984.90 Million |
+11.78% |
| 2004-12-31 | Skr8.19 Billion ≈ $881.14 Million |
-3.69% |
| 2003-12-31 | Skr8.50 Billion ≈ $914.94 Million |
+34.53% |
| 2002-12-31 | Skr6.32 Billion ≈ $680.08 Million |
-- |
About Getinge AB ser. B
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solu… Read more